People On The Move: Appointments At ProBiotix, EMA, Neuraxpharm
Executive Summary
A round-up of the latest European industry appointments: ProBiotix Health names Steen Andersen as its first permanent CEO; EMA appoints Steffen Thirstrup as chief medical officer; Neuraxpharm hires former Almirall exec Alfredo Barón to lead its Spanish business.
You may also be interested in...
ProBiotix Capitalizes On EU Monacolins Restriction With CholBiome Extension
A recent decision by the European Commission provides UK microbiome specialist ProBiotix Health with an opportunity to present its CholBiome extension as an alternative to red yeast rice as a way to “maintain normal blood cholesterol levels.”
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.